Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50009421
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083490((R)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 0.100nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083469((R)-3-(5-Chloro-thiophen-2-yl)-3-{[(R)-1-(3-piperi...)
Affinity DataIC50: 0.100nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083492((S)-3-(6-Methyl-pyridin-3-yl)-3-{[(R)-1-(3-piperid...)
Affinity DataIC50: 0.130nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083453((S)-3-(6-Chloro-pyridin-3-yl)-3-{[(R)-1-(3-piperid...)
Affinity DataIC50: 0.140nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083456((S)-3-(5-Bromo-pyridin-3-yl)-3-{[(R)-1-(3-piperidi...)
Affinity DataIC50: 0.210nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083479((R)-5-Phenyl-3-{[(R)-1-(3-piperidin-4-yl-propionyl...)
Affinity DataIC50: 0.220nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083496((R)-3-Benzo[1,3]dioxol-5-yl-3-({(R)-1-[3-(1-methyl...)
Affinity DataIC50: 0.240nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083455((S)-3-(5-Ethynyl-pyridin-3-yl)-3-{[(R)-1-(3-piperi...)
Affinity DataIC50: 0.240nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083467((S)-5-Phenyl-3-{[(R)-1-(3-piperidin-4-yl-propionyl...)
Affinity DataIC50: 0.290nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083495((S)-3-(5,6-Dichloro-pyridin-3-yl)-3-{[(R)-1-(3-pip...)
Affinity DataIC50: 0.340nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083478((R)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 0.360nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083449((R)-4-Phenyl-3-{[(R)-1-(3-piperidin-4-yl-propionyl...)
Affinity DataIC50: 0.370nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083466((R)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 0.370nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083466((R)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 0.370nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083471((S)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 0.370nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083482((R)-3-Benzo[1,3]dioxol-5-yl-3-{[(R)-1-(3-piperidin...)
Affinity DataIC50: 0.5nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083480((S)-3-(5-Phenyl-pyridin-3-yl)-3-{[(R)-1-(3-piperid...)
Affinity DataIC50: 0.520nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083465((S)-3-{[(R)-1-((E)-3-Piperidin-4-yl-acryloyl)-pyrr...)
Affinity DataIC50: 0.580nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083487((S)-3-{[(R)-1-([1,4']Bipiperidinyl-4-carbonyl)-pip...)
Affinity DataIC50: 0.650nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083447((S)-3-(5-Phenethyl-pyridin-3-yl)-3-{[(R)-1-(3-pipe...)
Affinity DataIC50: 0.660nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083448((S)-3-({(R)-1-[3-(1-Iminomethyl-piperidin-4-yl)-pr...)
Affinity DataIC50: 0.75nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083483((S)-3-{[(R)-1-((E)-3-Piperidin-4-yl-acryloyl)-pipe...)
Affinity DataIC50: 0.810nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083475((S)-3-(5-Phenylethynyl-pyridin-3-yl)-3-{[(R)-1-(3-...)
Affinity DataIC50: 0.850nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083462(3-{[1-(3-Piperidin-4-yl-propionyl)-piperidine-3-ca...)
Affinity DataIC50: 1.5nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083450((S)-3-{[(R)-4-(3-Piperidin-4-yl-propionyl)-piperaz...)
Affinity DataIC50: 1.70nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083488(3-(5-Phenyl-pyridin-3-yl)-3-{[1-(3-piperidin-4-yl-...)
Affinity DataIC50: 1.80nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083460(Xemilofiban hydrochloride | SC-54684 | 3-[3-(4-Car...)
Affinity DataIC50: 2nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083494(3-{[1-(3-Piperidin-4-yl-propionyl)-piperidine-3-ca...)
Affinity DataIC50: 2nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083461(3-{[1-(3-Piperidin-4-yl-propionyl)-piperidine-3-ca...)
Affinity DataIC50: 3nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083493(3-(5-Bromo-pyridin-3-yl)-3-{[1-(3-piperidin-4-yl-p...)
Affinity DataIC50: 3nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083459(2-Hydroxy-3-{[(R)-1-(3-piperidin-4-yl-propionyl)-p...)
Affinity DataIC50: 3.5nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083489(3-[5-(3-Amino-phenyl)-pyridin-3-yl]-3-{[1-(3-piper...)
Affinity DataIC50: 3.60nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083468((S)-3-(5-Chloro-6-methoxy-pyridin-3-yl)-3-{[(R)-1-...)
Affinity DataIC50: 3.80nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083454((S)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 3.80nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083452(3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperidine-...)
Affinity DataIC50: 4.80nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083476((S)-6,6-Dimethyl-3-{[(R)-1-(3-piperidin-4-yl-propi...)
Affinity DataIC50: 5.60nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083473((S)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 7.20nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083464(3-[5-(3-Methoxy-phenyl)-pyridin-3-yl]-3-{[1-(3-pip...)
Affinity DataIC50: 11nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083472(3-[5-(4-Methoxy-phenyl)-pyridin-3-yl]-3-{[1-(3-pip...)
Affinity DataIC50: 11nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083474(3-[5-(2-Methoxy-phenyl)-pyridin-3-yl]-3-{[1-(3-pip...)
Affinity DataIC50: 12nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083463((R)-3-{[(R)-1-(3-Piperidin-4-yl-propionyl)-piperid...)
Affinity DataIC50: 13.5nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083470(3-[5-(3-Nitro-phenyl)-pyridin-3-yl]-3-{[1-(3-piper...)
Affinity DataIC50: 14nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083491((2R,3R)-2-Hydroxy-4-phenyl-3-{[(R)-1-(3-piperidin-...)
Affinity DataIC50: 17.9nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083451(3-{[1-(3-Piperidin-4-yl-propionyl)-piperidine-3-ca...)
Affinity DataIC50: 24nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083486(3-(5-Naphthalen-1-yl-pyridin-3-yl)-3-{[1-(3-piperi...)
Affinity DataIC50: 26nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083477(3-(5-Benzofuran-2-yl-pyridin-3-yl)-3-{[1-(3-piperi...)
Affinity DataIC50: 36nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083481((R)-6,6-Dimethyl-3-{[(R)-1-(3-piperidin-4-yl-propi...)
Affinity DataIC50: 42nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083485((R)-3-Benzo[1,3]dioxol-5-yl-3-{[(R)-1-(3-piperidin...)
Affinity DataIC50: 48nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083484(3-(5-Naphthalen-2-yl-pyridin-3-yl)-3-{[1-(3-piperi...)
Affinity DataIC50: 57nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50083458(3-[5-(5-Chloro-thiophen-2-yl)-pyridin-3-yl]-3-{[1-...)
Affinity DataIC50: 57nMAssay Description:In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: